This Swedish Biotech Takes a Two-Pronged Approach to Cancer Treatment
This week we are in Lund, a city at the Southern tip of Sweden, where…
08/09/2017 - 2 minutes
Alex Dale
A former journalist intern at Labiotech, Alex now works as a copywriter in healthcare advertising. When he's not writing, he enjoys playing sports and long-distance cycling.
Spanish Biotech Receives €4.2 Million To Continue Development of Anti-Cancer Peptide
Investment will allow Peptomyc to continue the development of their peptide cancer therapy with reduced…
07/09/2017 - 2 minutes
Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug
A study of Verona's combination therapy for COPD observed a clinical improvement in lung function…
07/09/2017 - 2 minutes
Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment
Tiziana makes moves towards a €37B market with an oral monoclonal antibody (mAb) formulation to…
06/09/2017 - 3 minutes
British Biotech Moves One Step Closer to Solution to Tackle Crop-Damaging Moths
Oxitec has expanded beyond mosquitoes and commenced field trials of its genetically engineered diamondback moth (DBM)…
05/09/2017 - 2 minutes
